barr 446 (Tamoxifen 10 mg)

Pill imprint barr 446 has been identified as Tamoxifen citrate 10 mg.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for barr 446 (Tamoxifen 10 mg)

Tamoxifen citrate 10 mg barr 446
Tamoxifen citrate 10 mg barr 446 Front
Tamoxifen citrate 10 mg barr 446 Back
Tamoxifen citrate
Imprint:
barr
446
Strength:
10 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Barr Laboratories, Inc.
National Drug Code (NDC):
00555-0446
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00591-2232 Watson Pharmaceuticals, Inc. (now Actavis, Inc)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web1)